机译:在≥70岁≥70岁的患者中,强化诱导化疗与基于低甲基化剂的方案,新诊断术急性髓性白血病
Mario Lemieux Center for Blood CancersUniversity of Pittsburgh Medical CenterPittsburgh PA USA;
Mario Lemieux Center for Blood CancersUniversity of Pittsburgh Medical CenterPittsburgh PA USA;
Mario Lemieux Center for Blood CancersUniversity of Pittsburgh Medical CenterPittsburgh PA USA;
Mario Lemieux Center for Blood CancersUniversity of Pittsburgh Medical CenterPittsburgh PA USA;
Mario Lemieux Center for Blood CancersUniversity of Pittsburgh Medical CenterPittsburgh PA USA;
Mario Lemieux Center for Blood CancersUniversity of Pittsburgh Medical CenterPittsburgh PA USA;
Mario Lemieux Center for Blood CancersUniversity of Pittsburgh Medical CenterPittsburgh PA USA;
Mario Lemieux Center for Blood CancersUniversity of Pittsburgh Medical CenterPittsburgh PA USA;
Mario Lemieux Center for Blood CancersUniversity of Pittsburgh Medical CenterPittsburgh PA USA;
Mario Lemieux Center for Blood CancersUniversity of Pittsburgh Medical CenterPittsburgh PA USA;
Mario Lemieux Center for Blood CancersUniversity of Pittsburgh Medical CenterPittsburgh PA USA;
Mario Lemieux Center for Blood CancersUniversity of Pittsburgh Medical CenterPittsburgh PA USA;
AML; hypomethylating agent; intensive chemotherapy;
机译:在≥70岁≥70岁的患者中,强化诱导化疗与基于低甲基化剂的方案,新诊断术急性髓性白血病
机译:新诊断为急性髓性白血病的70岁以上患者的强化化学疗法
机译:低甲基化试剂+ venetoclax诱导治疗急性髓细胞白血病强化化疗 - 小型威尼斯群持续时间和发展中国家基线感染患者的新途径
机译:基于3 rd sup>多项式的K均值聚类基于急性髓细胞白血病(AML)和急性淋巴细胞白血病(ALL)的归一化
机译:急性髓细胞白血病对骨髓内皮细胞的粘附为化疗提供了保护
机译:低甲基化试剂+ venetoclax在急性髓性白血病中的诱导疗法不适合强化化疗 - 小型威尼虫持续时间和发展中国家基线感染患者的新途径
机译:老年人从诱导化疗中受益:高剂量尿催化剂(“5 + 1”)诱导化疗方案在新诊断术术急性髓性白血病中
机译:Brown Norway大鼠可移植骨髓性白血病的化疗:BNmL作为人类急性髓性白血病模型的研究